NCT00723866View on ClinicalTrials.gov

Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

June 30, 2008

Conditions
Stroke
Interventions
OTHER

BtxA+mCIMT

The combination group receive BtxA+mCIMT for 2 hours/day, 3 days/week for 3 months.

OTHER

BtxA+ conventional rehabilitation

The control group received for 2 hours/day, 3 days/week for 3 months.

All Listed Sponsors
lead

Kaohsiung Veterans General Hospital.

OTHER

NCT00723866 - Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity | Biotech Hunter | Biotech Hunter